Surgical Prophylaxis - Help
Back to DashboardOverview
The Surgical Prophylaxis module provides real-time monitoring and validation of surgical antibiotic prophylaxis following ASHP/IDSA/SHEA/SIS clinical practice guidelines. The module validates agent selection, timing, duration, and dosing for perioperative antibiotics.
Screening Workflow
The Surgical Prophylaxis module performs retrospective monitoring of surgical cases to evaluate compliance with antibiotic prophylaxis guidelines. It queries the FHIR server for completed surgical procedures, evaluates each case against 7 bundle elements, and generates alerts for non-compliant cases.
Timing Guidelines
| Antibiotic Class | Recommended Timing | Notes |
|---|---|---|
| Standard antibiotics (cefazolin, ampicillin-sulbactam) |
Within 60 minutes of incision | Optimal: 30-60 minutes before |
| Vancomycin | Within 120 minutes of incision | Requires slow infusion (1-2 hours) |
| Fluoroquinolones | Within 120 minutes of incision | Longer infusion time required |
Duration Guidelines
| Procedure Type | Maximum Duration | Notes |
|---|---|---|
| Most procedures | ≤24 hours post-op | Single dose often sufficient for clean procedures |
| Cardiac surgery | ≤48 hours post-op | Extended duration acceptable |
| Clean procedures | Single dose | No post-op doses needed |
Key Principle: Prophylaxis should be discontinued within 24 hours for most procedures. Extended duration does not reduce SSI risk and increases resistance.
Re-dosing During Surgery
For prolonged procedures, re-dosing is recommended based on antibiotic half-life (intervals for normal GFR >60):
| Antibiotic | Re-dose Interval | From First Dose |
|---|---|---|
| Cefazolin | Every 3 hours | Re-dose if surgery >3 hours |
| Cefoxitin | Every 3 hours | Re-dose if surgery >3 hours |
| Ceftriaxone | Every 12 hours | Re-dose if surgery >12 hours |
| Ampicillin-sulbactam | Every 2 hours | Re-dose if surgery >2 hours |
| Clindamycin | Every 6 hours | Re-dose if surgery >6 hours |
| Vancomycin | Every 8 hours | Re-dose if surgery >8 hours |
| Metronidazole | Every 12 hours | Re-dose if surgery >12 hours |
Also re-dose if significant blood loss (>1500 mL) occurs during surgery. Extend intervals for renal impairment.
Weight-Based Dosing
| Antibiotic | Pediatric Dose | Max Dose | High-Weight Adjustment |
|---|---|---|---|
| Cefazolin | 40 mg/kg IV | 2g | ≥100 kg: 3g IV |
| Cefoxitin | 40 mg/kg IV | 2g | - |
| Ceftriaxone | 50 mg/kg IV | 2g | - |
| Metronidazole | 15 mg/kg IV (30 mg/kg for appendectomy) | 1g (1.5g for appendectomy) | - |
| Vancomycin | 15 mg/kg IV | 2g per dose | Consult pharmacy |
| Clindamycin | 10 mg/kg IV | 900 mg | - |
| Gentamicin | 4.5 mg/kg IV | 160 mg (<40 kg) / 360 mg (≥40 kg) | Use adjusted body weight if obese |
Procedure-Specific Recommendations
Cardiac Surgery
- Primary: Cefazolin 40 mg/kg (max 2g; 3g if ≥100 kg)
- MRSA risk/colonized: Add vancomycin 15 mg/kg
- Beta-lactam allergy: Clindamycin or Vancomycin
- Duration: ≤48 hours (post-op continuation optional)
Appendectomy
- Primary: Ceftriaxone 50 mg/kg (max 2g) + Metronidazole 30 mg/kg (max 1.5g)
- Beta-lactam allergy: Clindamycin + Gentamicin
- Perforated appendectomy: Continue prophylaxis for 24 hours post-op
- Duration: ≤24 hours
Colorectal Surgery
- Primary: Cefoxitin 40 mg/kg (max 2g)
- Beta-lactam allergy: Clindamycin + Gentamicin
- Note: No post-op continuation - stop after surgery
- Duration: ≤24 hours
Orthopedic Surgery (with implant)
- Primary: Cefazolin 40 mg/kg (max 2g; 3g if ≥100 kg)
- MRSA colonized: Add vancomycin
- Beta-lactam allergy: Vancomycin or clindamycin
- Duration: ≤24 hours
Neurosurgery
- Craniotomy: Cefazolin 40 mg/kg (max 2g)
- CSF shunt: Cefazolin 40 mg/kg (some add vancomycin)
- Spinal with hardware: Cefazolin 40 mg/kg
- Duration: ≤24 hours
ENT Surgery
- Primary: Ampicillin-sulbactam 75 mg/kg (max 3g)
- Clean procedures (cochlear implant): Cefazolin 40 mg/kg
- Beta-lactam allergy: Clindamycin
- Duration: ≤24 hours
MRSA Considerations
Add vancomycin to standard prophylaxis when:
- Known MRSA colonization (positive nasal screen)
- Recent MRSA infection
- High institutional MRSA rates
- Cardiac surgery with sternotomy
- Orthopedic surgery with implant (per institutional protocol)
Note: Vancomycin should be added to (not replace) cefazolin for gram-negative coverage.
Allergy Alternatives
| Allergy Type | Can Use | Avoid |
|---|---|---|
| Penicillin (any severity) | Cefazolin (safe per current cross-reactivity evidence) | Ampicillin, piperacillin, ampicillin-sulbactam |
| Cephalosporin allergy | Clindamycin (preferred), Vancomycin | All cephalosporins |
| All beta-lactam allergy | Clindamycin ± Gentamicin (for gram-negative coverage) | All beta-lactams |
Note: Per current evidence, cefazolin cross-reactivity with penicillin is <1%. Cefazolin is safe to give to patients with ANY severity of penicillin allergy.
Compliance Bundle Elements
The module evaluates 7 key bundle elements for each surgical case:
| # | Element | Description |
|---|---|---|
| 1 | Indication Appropriate | Prophylaxis given (or withheld) appropriately for the procedure |
| 2 | Agent Selection | Correct antibiotic(s) for the procedure type and patient allergies |
| 3 | Pre-op Timing | Administered within 60 min of incision (120 min for vancomycin) |
| 4 | Weight-Based Dosing | Appropriate dose for patient weight (mg/kg with max caps) |
| 5 | Intraoperative Redosing | Redose given for prolonged surgery (e.g., Q3H for cefazolin) |
| 6 | Post-op Continuation | Appropriate post-operative prophylaxis when required (e.g., perforated appendectomy: 24h) |
| 7 | Timely Discontinuation | Stopped within 24h (48h for cardiac) |
Bundle Compliance: A case is considered fully compliant when ALL applicable elements are met.
References
- CCHMC Surgical Prophylaxis Guidelines v2024.2 (September 2024) - Local institutional guidelines
- Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283.
- ASHP/IDSA/SHEA/SIS. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. 2013.
- Ban KA, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017.